NuCana (NCNA) Stock Chart & Stock Price History → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free NCNA Stock Alerts $3.61 -0.01 (-0.28%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends NuCana Stock Price Performance5 Day Performance+2.56%1 Month Performance-9.30%3 Month Performance-54.88%6 Month Performance-65.62%Year-To-Date Performance-51.18%1 Year Performance-83.01% Receive NCNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… NCNA Stock Chart for Sunday, June, 2, 2024 NCNA Chart by TradingView NuCana Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.70$3.61-2.43%$3.71$3.538,950 shs$9.53 million05/30/2024$3.59$3.70+3.21%$3.73$3.607,447 shs$9.77 million05/29/2024$3.63$3.59-1.24%$3.68$3.528,758 shs$9.48 million05/28/2024$3.52$3.63+3.13%$3.85$3.536,492 shs$9.58 million05/27/2024$3.52$3.52$3.75$3.529,500 shs$9.29 million05/24/2024$3.54$3.52-0.42%$3.75$3.528,954 shs$9.30 million Get the Latest News and Ratings for NCNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$3.59$3.54-1.53%$3.86$3.545,286 shs$9.33 million05/22/2024$3.55$3.59+1.13%$3.70$3.4614,493 shs$9.48 million05/21/2024$3.60$3.55-1.39%$3.78$3.4514,980 shs$9.37 million05/20/2024$3.57$3.60+0.84%$3.74$3.4764,563 shs$9.50 million05/17/2024$3.70$3.60-2.70%$3.79$3.5622,093 shs$9.50 million05/16/2024$3.80$3.70-2.63%$3.87$3.6714,909 shs$9.77 million05/15/2024$3.78$3.80+0.53%$3.98$3.7724,956 shs$10.03 million05/14/2024$3.73$3.78+1.34%$3.88$3.6814,073 shs$9.98 million05/13/2024$3.59$3.73+3.90%$3.87$3.5419,482 shs$9.85 million05/10/2024$3.50$3.56+1.71%$3.62$3.4115,818 shs$7.38 million05/09/2024$3.76$3.50-6.91%$3.81$3.4135,324 shs$7.61 million05/08/2024$3.91$3.76-3.84%$4.34$3.53328,945 shs$7.78 million05/07/2024$3.88$3.91+0.77%$4.01$3.875,505 shs$8.09 million05/06/2024$4.00$3.88-3.00%$4.00$3.8731,444 shs$8.03 million05/03/2024$3.97$3.95-0.38%$4.18$3.8928,655 shs$8.18 million05/02/2024$3.98$3.97-0.38%$4.04$3.858,398 shs$8.21 million05/01/2024$4.01$3.98-0.75%$4.10$3.836,268 shs$8.24 million04/30/2024$4.00$4.01+0.25%$4.01$3.849,408 shs$8.30 million04/29/2024$4.00$4.00$4.28$3.9613,808 shs$8.28 million04/26/2024$3.84$4.00+4.17%$4.00$3.857,152 shs$8.36 million04/25/2024$3.83$3.84+0.26%$4.00$3.5416,490 shs$8.03 million04/24/2024$4.00$3.83-4.25%$4.09$3.7512,017 shs$8.01 million04/23/2024$3.99$4.00+0.25%$4.13$3.8237,241 shs$8.36 million04/22/2024$3.78$3.99+5.70%$4.20$3.8150,827 shs$8.34 million04/19/2024$3.79$3.78-0.26%$3.82$3.4032,622 shs$7.90 million04/18/2024$3.97$3.79-4.53%$4.18$3.6188,508 shs$7.92 million04/17/2024$3.90$3.97+1.79%$4.40$3.84108,050 shs$207.59 million04/16/2024$4.45$3.90-12.36%$5.14$3.69121,259 shs$203.93 million04/15/2024$5.60$4.45-20.50%$5.68$4.4431,893 shs$9.31 million04/12/2024$5.92$5.60-5.37%$5.98$5.3810,438 shs$11.71 million04/11/2024$5.92$5.92$5.99$5.754,879 shs$12.37 million04/10/2024$5.92$5.92-0.04%$5.93$5.639,024 shs$12.37 million04/09/2024$5.90$5.92+0.30%$6.10$5.6412,318 shs$12.38 million04/08/2024$5.82$5.90+1.42%$6.04$5.6712,574 shs$12.34 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$6.00$5.82-2.96%$6.10$5.6510,163 shs$12.17 million04/04/2024$6.56$6.00-8.58%$6.56$5.617,114 shs$12.54 million04/03/2024$5.75$6.56+14.14%$6.56$5.6018,072 shs$13.72 million04/02/2024$5.93$5.75-3.04%$6.13$5.6125,075 shs$12.02 million04/01/2024$6.50$5.93-8.85%$6.28$5.6820,407 shs$12.39 million03/29/2024$6.50$6.50$6.88$5.8651,815 shs$13.60 million03/28/2024$7.81$6.50-16.75%$6.88$5.8651,607 shs$13.60 million03/27/2024$7.70$7.81+1.40%$7.81$7.3119,979 shs$16.33 million03/26/2024$7.85$7.70-1.85%$7.85$7.0118,932 shs$16.11 million03/25/2024$7.60$7.85+3.19%$8.08$7.5013,090 shs$16.41 million03/22/2024$7.24$7.60+4.97%$7.86$7.2515,199 shs$15.90 million03/21/2024$8.32$7.24-12.92%$8.50$7.2341,385 shs$15.15 million03/20/2024$8.36$8.32-0.51%$8.50$8.1010,053 shs$17.40 million03/19/2024$9.18$8.36-8.88%$8.75$8.1318,339 shs$17.49 million03/18/2024$8.72$9.18+5.25%$9.50$7.6349,954 shs$19.19 million03/15/2024$9.77$8.72-10.77%$9.25$8.1684,659 shs$18.23 million03/14/2024$10.50$9.77-6.95%$10.50$9.03163,012 shs$20.44 million03/13/2024$9.77$10.50+7.47%$19.30$10.502.57 million shs$21.96 million03/12/2024$8.25$9.77+18.42%$11.00$8.00623,865 shs$20.44 million03/11/2024$8.29$8.25-0.42%$8.48$7.751,984 shs$17.26 million03/08/2024$8.25$8.29+0.42%$8.50$7.564,429 shs$17.33 million03/07/2024$8.06$8.25+2.39%$8.25$7.5111,186 shs$17.26 million03/06/2024$8.23$8.06-2.04%$8.45$7.907,450 shs$16.85 million03/05/2024$8.25$8.23-0.30%$8.73$7.882,192 shs$17.20 million03/04/2024$8.00$8.25+3.13%$9.00$7.887,190 shs$17.26 million03/01/2024$8.00$8.00$8.38$7.632,735 shs$16.73 million02/29/2024$8.21$8.00-2.53%$8.50$7.972,767 shs$16.73 million Related Companies: VYNE Therapeutics Stock Chart Eyenovia Stock Chart Cara Therapeutics Stock Chart Lipocine Stock Chart Fortress Biotech Stock Chart Marker Therapeutics Stock Chart Xilio Therapeutics Stock Chart Neoleukin Therapeutics Stock Chart Unicycive Therapeutics Stock Chart RenovoRx Stock Chart Receive NCNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NCNA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.